Search Results - Steven Sun

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Using VBIM Technique to Discover ARMC4/ODAD2 as a Novel Negative Regulator of NF-κB and a New Tumor Suppressor in Colorectal Cancer

    Using VBIM Technique to Discover ARMC4/ODAD2 as a Novel Negative Regulator of NF-κB and a New Tumor Suppressor in Colorectal Cancer by Matthew Martin, Rasika Mundade, Antja-Voy Hartley, Guanglong Jiang, Jiamin Jin, Steven Sun, Ahmad Safa, George Sandusky, Yunlong Liu, Tao Lu

    Published 2022-03-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer

    Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer by Antja-Voy Hartley, Benlian Wang, Guanglong Jiang, Han Wei, Mengyao Sun, Lakshmi Prabhu, Matthew Martin, Ahmad Safa, Steven Sun, Yunlong Liu, Tao Lu

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial

    Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial by Sriram Balasubramanian, Brendan Hodkinson, Stephen J. Schuster, Nathan H. Fowler, Judith Trotman, Georg Hess, Bruce D. Cheson, Michael Schaffer, Steven Sun, Sanjay Deshpande, Jessica Vermeulen, Gilles Salles, Ajay K. Gopal

    Published 2022-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    The Association Between Patient Satisfaction and Patient-Reported Health Outcomes

    The Association Between Patient Satisfaction and Patient-Reported Health Outcomes by Qinyu Chen MHS, Eliza W Beal MD, MS, Victor Okunrintemi MD, MPH, Emily Cerier BS, Anghela Paredes MD, Steven Sun MD, Griffin Olsen BA, Timothy M Pawlik MD, MPH, PhD

    Published 2019-09-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non‐germinal centre B‐cell‐like diffuse large B‐cell lymphoma: A Chinese subgroup analysis of the phase III PHOENIX trial

    Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non‐germinal centre B‐cell‐like diffuse large B‐cell ly... by Jun Zhu, Xiaonan Hong, Yu Qin Song, Brendan Hodkinson, Sriram Balasubramanian, Songbai Wang, Qingyuan Zhang, Yuankai Shi, Huiqiang Huang, Huilai Zhang, Yan Zhu, Stephen Martin Shreeve, Steven Sun, Ze Wang, Xiaocan Wang, Yue Fan, Wyndham Wilson, Jessica Vermeulen

    Published 2022-11-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue

    Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue by Lakshmi Prabhu, Matthew Martin, Lan Chen, Özlem Demir, Jiamin Jin, Xiumei Huang, Aishat Motolani, Mengyao Sun, Guanglong Jiang, Harikrishna Nakshatri, Melissa L. Fishel, Steven Sun, Ahmad Safa, Rommie E. Amaro, Mark R. Kelley, Yunlong Liu, Zhong-Yin Zhang, Tao Lu

    Published 2023-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open‐label phase 3 study

    Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open‐label phase 3 study by Xiaojun Huang, Lugui Qiu, Jie Jin, Daobin Zhou, Xiequn Chen, Ming Hou, Jianda Hu, Yu Hu, Xiaoyan Ke, Junmin Li, Yingmin Liang, Ting Liu, Yue Lv, Hanyun Ren, Aining Sun, Jianmin Wang, Chunting Zhao, Mariya Salman, Steven Sun, Angela Howes, Jingzhao Wang, Peng Wu, Jianyong Li

    Published 2018-04-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.

    Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types. by Craig P Giacomini, Steven Sun, Sushama Varma, A Hunter Shain, Marilyn M Giacomini, Jay Balagtas, Robert T Sweeney, Everett Lai, Catherine A Del Vecchio, Andrew D Forster, Nicole Clarke, Kelli D Montgomery, Shirley Zhu, Albert J Wong, Matt van de Rijn, Robert B West, Jonathan R Pollack

    Published 2013-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: